fostemsavir (Rukobia)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

  • 600 mg q12 hours

Adverse effects

Mechanism of action

More general terms

References

  1. FDA NEWS RELEASE. July 02, 2020 FDA Approves New HIV Treatment for Patients With Limited Treatment Options. https://www.fda.gov/news-events/press-announcements/fda-approves-new-hiv-treatment-patients-limited-treatment-options
  2. Kozal M, Aberg J, Pialoux G et al Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. N Engl J Med. 2020 Mar 26;382(13):1232-1243. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32212519 Clinical Trial.

Database